MedPath

University of Minnesota Masonic Cancer Center

🇺🇸United States
Ownership
Private
Employees
-
Market Cap
-
Website

NF-1, Nutraceutical Intervention

Phase 1
Recruiting
Conditions
Neurofibromatosis 1
Interventions
Dietary Supplement: curcumin, high phenolic extra virgin olive oil (HP-EVOO)
First Posted Date
2022-05-05
Last Posted Date
2024-05-16
Lead Sponsor
Masonic Cancer Center, University of Minnesota
Target Recruit Count
18
Registration Number
NCT05363267
Locations
🇺🇸

Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota, United States

Study of PAT in Patients With Solid Tumor Cancers

Phase 1
Suspended
Conditions
Solid Tumor
Metastasis
Interventions
First Posted Date
2022-04-21
Last Posted Date
2024-07-25
Lead Sponsor
Masonic Cancer Center, University of Minnesota
Target Recruit Count
21
Registration Number
NCT05338658
Locations
🇺🇸

Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States

HCW9218 in Select Advanced Solid Tumors

Phase 1
Active, not recruiting
Conditions
Solid Tumor
Interventions
First Posted Date
2022-04-11
Last Posted Date
2025-01-30
Lead Sponsor
Masonic Cancer Center, University of Minnesota
Target Recruit Count
18
Registration Number
NCT05322408
Locations
🇺🇸

Masonic Cancer Center - University of Minnesota, Minneapolis, Minnesota, United States

Sugars in Cigarettes

Not Applicable
Active, not recruiting
Conditions
Tobacco Use
Interventions
Other: Sucrose cigarettes
First Posted Date
2022-04-04
Last Posted Date
2025-04-08
Lead Sponsor
Masonic Cancer Center, University of Minnesota
Target Recruit Count
38
Registration Number
NCT05308316
Locations
🇺🇸

Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States

Ruxolitinib, Human Chorionic Gonadotropin (uhCG/EGF), and Dose De-escalated Corticosteroids

Phase 1
Recruiting
Conditions
Acute-graft-versus-host Disease
Interventions
First Posted Date
2021-11-17
Last Posted Date
2024-10-21
Lead Sponsor
Masonic Cancer Center, University of Minnesota
Target Recruit Count
55
Registration Number
NCT05123040
Locations
🇺🇸

Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States

PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation

Phase 1
Recruiting
Conditions
Myelodysplastic Syndromes
Acute Leukemia
Myeloproliferative Neoplasm
Lymphoma
Interventions
Drug: VIC- 1911
First Posted Date
2021-11-15
Last Posted Date
2024-04-22
Lead Sponsor
Masonic Cancer Center, University of Minnesota
Target Recruit Count
75
Registration Number
NCT05120570
Locations
🇺🇸

Masonic Cancer Center at University of Minnesota, Minneapolis, Minnesota, United States

Ph I/II Study of CAR19 Regulatory T Cells (CAR19-tTreg) for R/R CD19+ B-ALL

Phase 1
Withdrawn
Conditions
Lymphoma Leukemia
Interventions
Drug: allogeneic CAR19 regulatory T cells (CAR19-tTreg)
First Posted Date
2021-11-10
Last Posted Date
2024-07-19
Lead Sponsor
Masonic Cancer Center, University of Minnesota
Registration Number
NCT05114837
Locations
🇺🇸

Masonic Cancer Center - University of Minnesota, Minneapolis, Minnesota, United States

Fitness and Lung Function Among Survivors of Heart Transplant, Leukemia and Infant BPD Through Exercise

Not yet recruiting
Conditions
Acute Lymphoblastic Leukemia
Chronic Lung Disease
Chronic Obstructive Pulmonary Disease
Heart Transplant
Interventions
Other: Physical activity
First Posted Date
2021-08-27
Last Posted Date
2025-02-28
Lead Sponsor
Masonic Cancer Center, University of Minnesota
Target Recruit Count
90
Registration Number
NCT05025774

Telehealth-Filter Ventilation ( COMET2P1 )

Not Applicable
Completed
Conditions
Tobacco Use
Interventions
Other: Unventilated Cigarette Filter
Other: Ventilated Cigarette Filter
First Posted Date
2021-07-21
Last Posted Date
2025-05-08
Lead Sponsor
Masonic Cancer Center, University of Minnesota
Target Recruit Count
164
Registration Number
NCT04969783
Locations
🇺🇸

Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

🇺🇸

University of Minnesota Tobacco Research Program, Minneapolis, Minnesota, United States

Charcoal in Lung Cancer Patients Undergoing TEMLA

Phase 2
Withdrawn
Conditions
Lung Cancer
Interventions
First Posted Date
2021-06-16
Last Posted Date
2022-02-09
Lead Sponsor
Masonic Cancer Center, University of Minnesota
Registration Number
NCT04928950
© Copyright 2025. All Rights Reserved by MedPath